Burns Market by DelveInsight
DelveInsight's Burns Market Insights report proffers a detailed comprehension of Burns market size by treatment, epidemiology, emerging therapies, Burns market drivers, market barriers, and ongoing clinical trials. The report also provides an understanding of Burns market share of the individual therapies, current and forecasted Burns market size from 2018 to 2030 segmented into 7MM (the US, EU5 (the UK, Italy, Spain, France, and Germany), and Japan).
Some of the major takeaways from the Burns Market Report:
- The
Burns market size was USD 830 million in 2020 in the
United States. DelveInsight estimates suggest that the United
States had the highest incident population of burn injuries that
required medical treatment. The market size of Burns is expected to grow
at a CAGR of 1.96% in the 7MM for the study period
2018-2030.
- The
Burns pipeline therapies include DenovoSkin, CellMist System,
MW-III, and others, which may improve the treatment dynamics in
the upcoming future.
- Major
pharma giants working proactively in the Burns therapeutic market
include CUTISS AG, Skingenix, Polynovo, Mallinckrodt
Pharmaceuticals, Kerecis, MediWound Germany GmbH, Kaken
Pharmaceutical Co., Avita Medical, Vericel Corporation, KeraNetics, Integra
Life Sciences Corporation, Medline Industries, Anika Therapeutics, ACell,
Amryt Pharma, Skingenix, RenovaCare, and many more.
- The
Burns market is expected to be driven by factors such as the increasing
incidence, availability of a wide range of treatment options, and advancements
in burn care treatments and products.
- The
Burns market may be hampered by several factors including stringent
regulatory guidelines for the approval of new treatment or
medicine and high cost for the treatment.
- A
major breakthrough in Burns treatment is a bio-engineered DenovoSkin which
is being developed by CUTISS AG.
Download Burns Market sample to understand the comprehensive
treatment scenario @ https://www.delveinsight.com/report-store/burns-market
Burns: Overview
A Burn takes place when the skin comes into contact with a
heat source. Burns can occur from many different sources. The most common
sources that cause Burns are fire/flame, scalds, hot objects, electrical, and
chemical agents, respectively. Burns is a common injury seen in emergency
departments around the world. Even as emergency management improves, Burns
continues to have significant morbidity and mortality.
Request for a Webex demo of the report @ https://www.delveinsight.com/report-store/burns-market
Burns Epidemiology Segmentation
DelveInsight's analysis indicates that the majority of Burns
injury cases taking treatment are males due to most Burn cases
occurring at the workplace making males more vulnerable to Burns. There
were 411,066 male and 251,944 female cases of
treated burn injuries in 2020 in the United States.
In the same year, the Burns severity-specific estimated cases
were observed to be 144,536, 387,198, 19,890,
and 111,386 for first-degree, second-degree, third-degree, and
unspecified, respectively in the United States.
The Burns Market Report proffers
epidemiological analysis for the study period 2018-30 in the 7MM segmented
into:
- Incident
Cases of Burns Patient Requiring Treatment
- Gender-specific
Incident Cases of Treated Burn Injuries
- Etiology-specific
Incident Cases of Treated Burn Injuries
- Severity-specific
Incident Cases of Treated Burn Injuries
- Incident
Cases of Hospitalized Burns Patients
Know how Burns Epidemiological Trends are going to look like
in 2030 for the 7 MM by downloading @ https://www.delveinsight.com/report-store/burns-market
In the current market scenario, the standard treatment for
Burns involves medications, wound dressings, therapy, and surgery.
The Burns treatment goal is to control pain, remove dead tissue,
prevent infection, reduce scarring risk, and regain function.
The Burns treatment depends on the severity of the burn. Currently, some major
pharmaceutical companies like Kerecis, Polynovo, Mallinckrodt, are
marketing Burns treatment therapies like Kerecis Omega3, NovoSorb
BMT, and Stratagraft.
Despite the widespread availability of safe and effective
Burns medications and surgery options, pharmaceuticals like Cutiss AG, Skingenix, and
many more are developing novel Burns treatment therapies. One major
breakthrough therapeutic product DenovoSkin is being developed
by CUTISS AG which is bio-engineered with a thick, double
layer, robust structure. DenovoSkin is a patented, personalized, autologous
bio-engineered human skin graft classified as Advanced Therapy Medical
Product (ATMP). DenovoSkin has successfully completed Phase I. Another
therapeutic product is MW-III, by Skingenix, which
is a topical product being evaluated for second-degree burns in adult
patients.
To know about more pipeline therapies under different
development phases visit @ https://www.delveinsight.com/report-store/burns-market
The rise in the number of incident Burn cases can
be considered as a prominent factor for Burns market surge in the coming years.
The Burns market is expected to show positive growth, mainly attributed to
factors like increase in research and development activities, rise in
the number of clinical studies, increasing number of surgical procedures, the launch
of upcoming therapies, and the availability of a wider range
of treatment options.
However, unreported and undiagnosed Burns
cases and the absence of effective treatment are some of the
major blockades in the Burns market growth. Apart from that, stringent
regulatory guidelines are also applied for the approval of new
treatment with the high cost for the treatment of Burns which
may act as setbacks.
Scope of the Burns Market Report
- Study
Period: 2018-30
- Coverage: 7MM
[The United States, EU5 (Germany, France, Italy, Spain, and
the United Kingdom), and Japan.]
- Key
Companies: Mallinckrodt Pharmaceuticals, Polynovo, Kerecis,
CUTISS AG, Skingenix, MediWound Germany GmbH, Kaken Pharmaceutical Co.,
Avita Medical, Vericel Corporation, KeraNetics, Integra Life Sciences
Corporation, Medline Industries, Anika Therapeutics, ACell, Amryt Pharma,
Skingenix, RenovaCare, and many more
- Key Burns
Pipeline Therapies: DenovoSkin, CellMist System, MW-III, and
others
- Therapeutic
Assessment: Burns current marketed and emerging therapies
- Market
Dynamics: Burns market drivers and barriers
- Competitive
Intelligence Analysis: PEST Analysis
- Unmet
Needs
- KOL's
views
- Analyst's
views
- Market
Access and Reimbursement
Table of Contents
1 |
Key Insights |
2 |
Burns Report
Introduction |
3 |
Burns Market
overview at a glance |
4 |
Disease Background
and Overview: Burns |
5 |
Burns Epidemiology
and Patient Population (7MM) |
6 |
Burns: Country
Wise-Epidemiology |
7 |
Treatments &
Medical Practices in Burns |
8 |
Current Treatment
in Burns |
9 |
Burns Emerging
Treatment |
10 |
Burns Competitive
Analysis |
11 |
Burns: Seven Major
Market Analysis |
12 |
7MM: Burns
Country-wise Market Analysis |
13 |
Burns United
States Market Size |
14 |
Burns EU5 Market
Size |
15 |
Burns Japan Market
Size |
16 |
Burns Market
Drivers |
17 |
Burns Market
Barriers |
18 |
Report Methodology |
19 |
DelveInsight
Capabilities |
20 |
Disclaimer |
21 |
About DelveInsight |
DelveInsght’s Competitive
Intelligence Service includes a multidimensional coverage, helping to
keep track of competitors and gain traction in the dynamic market by overcoming
the challenges and expediting business growth through a strategic and tactical
approach.
Related Reports:
- Thymic
Carcinoma Market
- Asphyxia
Market
- Acute
Agitation And Aggression Market
- HPV-Induced
Cancers Market
- Diagnostic
Imaging Equipment Market
- Epilepsy
Market
- Bradykinesia
Market
- Immunologic
Deficiency Syndrome Market
- Wilms
Tumor Market
- Advanced
Wound Care Market
- Defibrillators
Market
- Diagnostic
Imaging Equipment Market
- Pulse
Oximeters Market
- Achromatopsia
Market
- Cataplexy
Market
Related Blogs:
- Social
Determinants of Health and their Impact on COVID-19
- Top
Drugs To Watch in HIV (2025)
- Gene
Therapy for Hemophilia: Progress and Setbacks
- IgA
Nephropathy – In-depth Assessment of the Emerging Therapies and Key
Companies in the Therapeutics Domain
- Smart
Hospital: How it is Shaping the Future of Healthcare Delivery
- An
in-depth Assessment of the Top Drugs Launched by Leading Global Companies
in 2021
About Delveinsight:
DelveInsight Business Research is a leading Market Research, and
Business Consultant focused purely on Healthcare. It helps pharma companies by
providing them with end-to-end services to solve their business problems.
Get hold of all the Pharma and healthcare market research
reports on our market research subscription-based platform PharmDelve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
Comments
Post a Comment